Text size We’re past the peak of first-quarter earnings season, but with several notable companies still left to report next week. The economic-data highlights of the week will be a pair of inflation ...
Tag: Healthcare/Life Sciences
Disney, Occidental, Rivian, Palantir, BioNTech, and Other Stocks for Investors to Watch This Week
Text size We’re past the peak of first-quarter earnings season, but with several notable companies still left to report next week. The economic-data highlights of the week will be a pair of inflation ...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...
Carvana, Robinhood and Teladoc Stock Give Way to Old-School Rivals. Here’s When It Might Be Safe to Buy.
Text size Carvana’s stock has fallen nearly 80% in the past 12 months. Mark Ralston/AFP/Getty Images It’s new school versus old school, and the new school doesn’t stand a chance. No, we’re not talking...
Bausch + Lomb, Year’s Second-Biggest IPO, Pops in Public Debut
Text size Bausch + Lomb’s IPO is the second-biggest so far this year. Scott Olson/Getty Images Eye-care company Bausch + Lomb and biotech PepGen kicked off their lives as public companies Friday...
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...
Teva CEO Sees a Final Opioid Settlement Coming This Year
Text size Teva CEO Kåre Schultz has been predicting a national opioid settlement for years. Christopher Goodney/Bloomberg Teva Pharmaceutical Industries CEO Kåre Schultz has, for years, been predictin...
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
A screen of stocks that popped during the coronavirus pandemic highlights dozens that have crashed. But some are considered worthy of purchase by a majority of analysts. You might want to keep an eye ...
James Anderson of Baillie Gifford on Illumina, Moderna, and Other Companies That Matter
James Anderson, a partner at Scottish money manager Baillie Gifford, has personified growth-stock investing during his 39 years with the firm. He was an early backer of Amazon.com, Tesla, and other “e...
Cathie Wood’s Flagship Fund Is Down 45% This Year. Money Is Still Flowing In.
Cathie Wood’s ARK Innovation exchange-traded fund keeps falling, but investors aren’t jumping ship. Shares of the popular ETF, which is known by its ticker ARKK, have declined 45% so far in 2022—inclu...
Why did the stock market fall? Dow finishes nearly 1,000 points lower in worst day since October 2020
U.S. stocks fell sharply on Friday to suffer their biggest one-day drop since 2020, as investors continued to weigh hawkish comments on interest rates a day earlier by Federal Reserve Chairman Jerome ...
As Putin eyes a date to declare victory, here’s a Ukraine scenario that could slam stocks by another 10%
Stocks are set to get a major bump on Thursday, thanks to blowout results from Tesla, which go some way in easing the sting over Netflix disappointment. With earnings sharply in focus for now, market ...
The news coming from this giant volcano is even gloomier than the new forecasts from the IMF and World Bank
Investors love looking at esoteric indicators for clues on how the economy is performing, and therefore how stocks, bonds and other assets will trade. How about looking at carbon dioxide emissions? Th...
Tesla, AT&T, Netflix, Bank of America, IBM, and Other Stocks to Watch This Week
Text size First-quarter earnings season picks up next week, with 67 S&P 500 companies scheduled to report. Bank of America will be Monday’s highlight, followed by Netflix , Johnson & Johnson ...
Here’s the playbook if the rest of the world breaks free from the U.S. dollar, says Credit Suisse’s monetary plumbing guru
It’s pretty well accepted that no one knows as much about the plumbing of the world’s financial system as Zoltan Pozsar, global head of short-term interest-rate strategy at Credit Suisse, who was the ...
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Opinion: Which jobs have come back, and which ones haven’t
Although the recovery in output, wealth and hours worked has been remarkable since February 2020, the U.S. economy remains deeply scarred by the COVID-19 pandemic. Total hours worked in the nonfarm ec...